Currently, there are no disease-modifying therapies for the treatment of Parkinson's disease; however, one potential strategy for treatment is to prevent α-synuclein aggregation. As a first step, researchers at Osaka University have developed a device that can assess the degree of α-synuclein aggregation in the brain.
Novel device opens new doors for Parkinso... - Cure Parkinson's
Novel device opens new doors for Parkinson's disease diagnostics
Written by
Farooqji
To view profiles and participate in discussions please or .
5 Replies
•
I like it...but I am unable to even begin to understand how this works. Ultrasonification !?...
it simply accurately detects α-synuclein aggregation in cerebrospinal fluid (by detecting seeding activity of α-synuclein aggregates in cerebrospinal fluid) using ultrasonification technique (sound energy at high frequencies )
Step by step details of the process are mentioned in the below link
I don’t understand “Currently, there are no disease-modifying therapies for the treatment of Parkinson's disease”??????
Maybe it is playing with words, but along with many thousands of patients, my PD is very modified with Prolopa Madopar)
Not what you're looking for?
You may also like...
The Endotoxin Hypothesis of Parkinson's Disease
Abstract: The endotoxin hypothesis of Parkinson's disease (PD) is the idea that...
Parkinson's disease and Medical Devices
Tech researching Parkinson's disease and I would love to hear your experiences with medical devices...
SYMBYX device for Parkinson's treatment
has experience of using SYMBYX device for Parkinson's Disease
https://symbyxbiome.com
any comment...
Protein Discovered in Parkinson’s Disease Could Lead to New Treatments
https://news.cuanschutz.edu/news-stories/protein-discovered-in-parkinsons-disease-could-lead-to-new-
Parkinson's Disease: emerging treatment target, the NLRP inflammasome.
cycle of neuroinflammation and α-synuclein buildup in the brain....